Purpose: The purpose of this trial is to:
- Assess the positive effects on growth of tumour cells
- Study effectiveness of drug on patients
- Assess and monitor any side effects
Eligibility: To be eligible to join this clinical trial you must:
- Be 19 years of age or over
- Have a measurable disease
- Have no brain metastases
- Not have received previous chemotherapy for the condition
- Not have had radiotherapy for at least four weeks
- Not have had surgery for at least two weeks
- Not have received treatment with the trial drug before
Treatment: The process will entail:
- Administering of drug once daily by mouth for as long as benefits are evident.
- Evalutions bi-monthly for a year; four monthly for a year; and twice yearly for a year.
Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.